Skip to main content
//empty //empty

Our roundup of Canadian small-caps of between $100-million and $2.5-billion in market capitalization making news and on the move today.

Just Energy Group Inc. (JE-T; JE-N) reported sales of $1-billion in the fourth quarter ended March 31, up 7 per cent from $947.3-million a year ago and below expectations of $1.1-billion. Profit came in at $265.8-million or $1.40 per share versus a loss of $38.2-million or 30 cents a year ago. Funds from operations were $25.5-million, down from $28.6-million a year ago.

**

Story continues below advertisement

Maricann Group Inc. (MARI-CN) says it plans to acquire Medican Holdings Ltd of the Republic of Malta for US$10.1-million in cash and shares. Medican Research Group, a subsidiary of Medican, is one of six companies approved to receive a license in Malta, the company stated. “This license will give Maricann the ability to import, extract, manufacture finished dose products, and distribute cannabis for medical purposes within Malta and the European Union,” it stated.

**

Input Capital Corp. (INP-X) says it generated adjusted sales from streaming contracts of $2.5-million on adjusted streaming volume of 5,159 metric tons (MT) for an average price of $482.66 per MT in the first quarter. That compared to $9.1-million on volume of 18,992 MT at an average price of $478.83 MT a year ago.

It said the decrease is due to “an early harvest accompanied by good harvest weather, which allowed for timely and smooth canola transportation and sale throughout the first quarter, translating into lower year-over-year sales in the second quarter of the 2018 fiscal year.”

Its adjusted loss was $370,000 versus income of $396,000 a year earlier.

**

Aethon Minerals Corp. (AET-X) says it has an option agreement with Sociedad Legal Minera La Florida De Canela, through its wholly-owned subsidiary Aethon Minerals Chile SpA, to acquire a 100-per-cent interest in the Llanos De Llahuin project in Chile. The deal includes a series of payments over 48 months.

Story continues below advertisement

The terms also give Sociedad a 2-per-cent net smelter return royalty “of which Aethon will maintain the exclusive option to acquire at any time, in its entirety, for a one-time cash payment of US$4,500,000,” the company said. “The back-end weighted option payment structure provides the company with a low-risk opportunity to conduct exploration activities in order to assess whether it will continue advancing the project.”

**

Hiku Brands Company Ltd. (HIKU-CN) says it will invest up to $1-million in cash and up to $2-million in shares for a 25-per-cent stake in Oceanic Releaf Inc., a Newfoundland and Labrador-based late-stage applicant under the Access to Cannabis for Medical Purposes Regulations. Hiku and Oceanic intend to become licensed for up to five cannabis retail locations within the province, and will enter into a retail agreement governing the operation of these stores,” the company stated.

**

ATS Automation Tooling Systems Inc. (ATA-T) reported fourth-quarter revenues of $298.4-million, up 12 per cent compared to the same period a year ago. Net income was $15-million or 16 cents per share compared to $7.8-million or 8 cents a year ago. Analysts were expecting earnings of 13 cents and revenue of $268.5-million.

**

Story continues below advertisement

Organigram Holdings Inc. (OGI-X) says it has received a permit to export cannabis from Health Canada that will allow the company to begin its first international shipments. “Organigram will now be able to ship dried cannabis products to Cannatrek Medical PTY Ltd., a licenced Australian medical cannabis enterprise with operations in Melbourne, Victoria through its broker Cannada Management Group Global Inc., the company said.

**

SDX Energy Inc. (SDX-X) reported net revenue of US$11-million in the quarter ended March 31 compared to US$8.1-million for the same period a year earlier. It generated income of $300,000 versus income of $26.9-million for the same period last year.

**

Namaste Technologies Inc. (N-X) says it has signed a supply agreement for the sale and distribution of RX Princeps, the medicinal marijuana brand of Tetra Natural Health, a division of Tetra Bio-Pharma (TBP-X). Namaste will purchase RX Princeps from Tetra Natural Health.

**

Story continues below advertisement

Golden Leaf Holdings Ltd. (GLH-CN) says it plans to acquire two large cannabis cultivation facilities and their associated cultivation licenses; one in Northern Nevada and another in Northern California, that are owned by the same operators. Golden Leaf says it will pay US$8.5 million in cash at closing, plus an undetermined number of shares that equals 25 per cent of the total issued and outstanding shares of its common stock.

**

Alaris Royalty Corp. (AD-T) says it will receive about $69.6-million from the sale of one of its investment companies, Labstat LP.

Alaris also announced that PF Growth Partners LLC has repurchased 48 per cent of the units Alaris holds that company for US$25-million, which it says is a 30-per-cent premium to Alaris’ cost.

Report an error Editorial code of conduct
Tickers mentioned in this story
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies